NextPlat (NASDAQ:NXPL) Trading Down 2.6% – Here’s Why

NextPlat Corp. (NASDAQ:NXPL)’s stock price was down 2.6% on Friday . The stock traded as low as $0.5640 and last traded at $0.5919. Approximately 170,300 shares traded hands during mid-day trading, a decline of 7% from the average daily volume of 182,279 shares. The stock had previously closed at $0.6080.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of NextPlat in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

NextPlat Trading Down 2.6%

The business has a fifty day moving average of $0.69 and a 200-day moving average of $0.74. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.80 and a current ratio of 3.56. The company has a market capitalization of $15.57 million, a P/E ratio of -1.97 and a beta of 1.16.

NextPlat (NASDAQ:NXPL) last announced its quarterly earnings results on Wednesday, November 12th. The company reported ($0.08) EPS for the quarter. NextPlat had a negative net margin of 14.58% and a negative return on equity of 34.22%. The business had revenue of $13.75 million for the quarter.

Hedge Funds Weigh In On NextPlat

An institutional investor recently bought a new position in NextPlat stock. Citadel Advisors LLC acquired a new position in NextPlat Corp. (NASDAQ:NXPL) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat as of its most recent SEC filing. 1.30% of the stock is owned by institutional investors.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.